Rangatira takes stake in Magritek
New Zealand private equity investor Rangatira has acquired a 12 per cent stake in benchtop NMR and MRI specialist Magritek for a non-disclosed sum. The transaction will strengthen Magritek’s balance sheet and enable the company to make a significant investment in its offshore sales and marketing following the launch

